Tata 1mg and Vitonnix UK get into an exclusive partnership in India

0
456
Tata 1mg and Vitonnix UK get into an exclusive partnership in India
Tata 1mg and Vitonnix UK get into an exclusive partnership in India

              – Launch Innovative Vitamin Sublingual Sprays

Mumbai/ New Delhi, 9th January 2024: Tata 1mg, India’s trusted digital healthcare platform, has joined forces with Vitonnix UK, a leading name in health and wellness innovation, to bring forth a first-of-its-kind offering in India. Jointly, they recently introduced a groundbreaking range of Vitamin Sublingual Sprays. This sublingual spray is applied directly under the tongue, thereby enabling the vitamins and supplements to be absorbed directly through the mucosal lining of the mouth which has a very rich blood supply.
The first phase of the launch includes four remarkable products: Vitamin D, Multivitamins, Biotin, and the star of the lineup, Melatonin. These sublingual sprays are designed to offer a convenient and effective way for individuals to take their daily vitamin and health supplements.
Sublingual administration is a revolutionary approach to taking vitamins and health supplements, offering several key benefits:
  • Rapid Absorption: Sublingual sprays get absorbed directly into the bloodstream through the mucous membranes under the tongue hence the vitamins are rapidly absorbed compared to other oral formulations (capsule/tablet/syrups).
  • Increased Bioavailability: Sublingual delivery bypasses the digestive system thereby offering higher bioavailability than traditional tablets and capsules. This means that more of the vitamins/supplements are available in the bloodstream for utilization by the body.
  • Convenience: These Sprays are convenient and easy to use, making them an excellent choice for individuals who have difficulty swallowing pills or capsules. They are also perfect for those with busy lifestyles.
  • Precise Dosage: Each spray delivers a precise dosage of vitamins and ensures consistency in supplementation.
Mr. Saurabh Goel, Vice President – Category Management at Tata 1mg, expressed his enthusiasm for this game-changing collaboration: “As Tata 1mg, our primary focus has always been the well-being of our customers. We understand the importance of innovation in healthcare, and after meticulously evaluating Vitonnix UK’s extensive research and development efforts, we are confident that these Vitamin Sublingual Sprays will empower individuals to take charge of their health in a new and convenient way.”
Mr. Satish Subramani, Managing Partner for Vitonnix UK, added, “We are thrilled to bring our state-of- the-art Vitamin Sublingual Sprays to India in partnership with Tata 1mg. This collaboration reflects our commitment to providing the Indian market with innovative health solutions that are both effective and convenient. Our partnership with Tata 1mg, India’s trusted digital healthcare brand, speaks volumes about the quality and credibility of our products.”
These Vitamin Sublingual Sprays represent a significant advancement in how individuals in India approach their nutritional needs. They offer a convenient, effective, and trusted solution that aligns with the evolving health preferences of consumers.
Phase 2 of the launch promises the introduction of several groundbreaking products. Vitonnix UK remains steadfast in its commitment to pushing the boundaries of health and wellness through cutting-edge technology and research. This ongoing commitment to innovation and excellence is set to further transform India’s health and wellness landscape. Stay tuned for more updates as Vitonnix UK and Tata 1mg continue to shape the future of health and wellness in India.